[Clinical study on unmodified intravenous dried ion-exchange resin treated human normal immunoglobulin, SM-4300].
Unmodified intravenous dried ion-exchange resin treated human normal immunoglobulin, SM-4300, was administered to 4 patients with severely intractable infectious diseases. Obvious antipyretic effect, opsonic effect and and investigational findings on healing are not observed. However, in both subjective and objective clinical effects, we obtained the following test results, that is, 1 case of effective and 2 cases of rather effective. No side effects by SM-4300 were observed.
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001424:Bacterial Infections / Q000628:therapy*; D001922:Brain Abscess / Q000628:therapy; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D004359:Drug Therapy, Combination; D006801:Humans; D007116:Immunization, Passive; D007136:Immunoglobulins / Q000008:administration & dosage*; D007263:Infusions, Parenteral; D007475:Ion Exchange Resins; D008171:Lung Diseases / Q000628:therapy; D008297:Male; D008875:Middle Aged; D013492:Suppuration; D014552:Urinary Tract Infections / Q000628:therapy
D000900:Anti-Bacterial Agents; D007136:Immunoglobulins; D007475:Ion Exchange Resins; C044640:SM-4300